Skip to content

Karen B. Jacobson, MD, MPH

karen.x.jacobson@kp.org

Karen  Jacobson, MD, MPH

Dr. Karen Jacobson joined the Vaccine Study Center at the Kaiser Permanente Northern California Division of Research in 2023 as a Research Scientist. She is a board-certified Infectious Diseases physician.

Dr. Jacobson obtained a bachelor of arts in Human Biology from Stanford University and a doctor of medicine and master of Public Health from the Icahn School of Medicine at Mount Sinai. She completed her residency training in Internal Medicine/HIV Primary Care at the Yale-New Haven Hospital and her fellowship in Infectious Diseases at Stanford.

Dr. Jacobson’s research is focused on mitigating sequelae of infectious diseases, particularly SARS-CoV-2. She is co-Investigator of multiple outpatient studies of treatments for acute and convalescent SARS-CoV-2 disease, and her published work has described clinical and immunologic correlations of Long COVID and risk of post-vaccination infection with SARS-CoV-2 variants of concern. Dr. Jacobson is the recipient of the Burroughs Wellcome-ASTMH Fellowship in Tropical Infectious Diseases, a Thrasher Fund Early Career Award, and a National Institute of Allergy and Infectious Diseases (NIAID)-funded Mentored Patient-Oriented Research Career Development Award (K23AI177817) evaluating sequelae of maternal SARS-CoV-2 infection and vaccination on early infant outcomes in Uganda.

Current Positions

  • Research Scientist

Section Affiliations

Primary Research Interests

  • Mitigating sequelae of infectious diseases
  • SARS-CoV-2 disease

Related Websites

Studies

Impact of gestational SARS-CoV-2 and maternal inflammation on child growth and neurodevelopment in a malaria-endemic setting

Leveraging longitudinal clinical data and samples from mother-infant dyads enrolled in two ongoing NIH-funded trials in Busia, Uganda, with high incidence of malaria and SARS-CoV-2, this study will evaluate the impact of gestational SARS-CoV-2 infection and vaccination on early childhood growth and neurodevelopment, and determine if the effect of gestational SARS-CoV-2 infection and vaccination on infant outcomes is mediated by specific maternal inflammatory pathways.

Investigator: Jacobson, Karen

Funder: National Institute of Allergy and Infectious Diseases

Back To Top